Direct accesses

  • Go to main menu
  • Go to main content
Menu
GenSight GenSight
Search the site
  • Contact
  • Careers
  • You are viewing the website in English en
  • fr
Search the site
  • Whowe are
    • Company
    • Leadership
    • Collaborations
  • Diseaseswe target
    • Diseases we target
    • Leber Hereditary Optic Neuropathy (LHON)
    • Retinitis Pigmentosa (RP)
    • Geographic Atrophy in Dry-AMD
  • Ourtechnologies
    • Technologies we are applying
    • Gene Therapy
    • Mitochondrial Targeting Sequence (MTS)
    • Optogenetics
    • Clinical development Summary
  • Investors
    • Company Overview
    • Financial press releases
    • Investor Newsletters
    • Events & presentations
    • Stock information & Financial agenda
    • Governance
    • Documentation
  • Media

Documentation

  • Home >
  • Investors & media >
  • Documentation
15 April 2026
Financial statements and reports, General Assembly, Regulated information

URD 2025 Open in new window

10 March 2026
Regulated information

ANNEX IX MARCH 2026 Open in new window

29 January 2026
Investor newsletter

INVESTOR NEWSLETTER – JANUARY 2026 (ENGLISH) Open in new window

29 January 2026
Investor newsletter

INVESTOR NEWSLETTER – JANUARY 2026 (FRENCH) Open in new window

28 January 2026
General Assembly, General meetings

Voting Result Open in new window

07 January 2026
General Assembly, General meetings

EGM January 2026 – Shares and voting rights statement Open in new window

07 January 2026
General Assembly, General meetings

EGM January 2026 – Rapport AK réservée aux salariés Open in new window

07 January 2026
General Assembly, General meetings

EGM January 2026 – Notice and Convening Brochure Open in new window

07 January 2026
General Assembly, General meetings

EGM January 2026 – Proxy voting form Open in new window

07 January 2026
General Assembly, General meetings

EGM January 2026 – Preliminary Notice of the General Meeting Open in new window

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 25
  • View next 9 articles
© 2026 Gensight Biologics
  • Terms of use
  • Sitemap
  • Contact
  • Credits
  • Cookies management
Go back to the page of the page